Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Eagle Pharmaceuticals Inc...

    OTC: EGRX · Real-Time Price · USD
    1.25
    -0.25 (-16.67%)
    At close: Apr 04, 2025, 3:30 PM

    Eagle Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 316.61M 171.55M
    Cost of Revenue
    		 94.94M 42.18M
    Gross Profit
    		 221.67M 129.37M
    Operating Income
    		 80.96M -2.91M
    Interest Income
    		 271K 560K
    Pretax Income
    		 61.43M -4.55M
    Net Income
    		 35.64M -8.63M
    Selling & General & Admin
    		 106.63M 75.32M
    Research & Development
    		 34.09M 51.27M
    Other Expenses
    		 n/a -6.24M
    Operating Expenses
    		 140.71M 126.6M
    Interest Expense
    		 4.04M 1.64M
    Selling & Marketing Expenses
    		 8.5M 8.5M
    Cost & Expenses
    		 235.65M 168.78M
    Income Tax Expense
    		 25.79M 4.08M
    Shares Outstanding (Basic)
    		 12.93M 13.05M
    Shares Outstanding (Diluted)
    		 13.07M 13.05M
    EPS (Basic)
    		 2.76 -0.66
    EPS (Diluted)
    		 2.73 -0.66
    EBITDA
    		 77.5M 2.77M
    EBIT
    		 65.48M -2.91M
    Depreciation & Amortization
    		 12.02M 4.81M

    Add to Watchlist